Yarlagadda S Babu - Net Worth and Insider Trading
Yarlagadda S Babu Net Worth
The estimated net worth of Yarlagadda S Babu is at least $1 Million dollars as of 2024-04-29. Yarlagadda S Babu is the Chief Discovery Officer of BioCryst Pharmaceuticals Inc and owns about 298,541 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $1 Million. Details can be seen in Yarlagadda S Babu's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Yarlagadda S Babu has not made any transactions after 2022-11-14 and currently still holds the listed stock(s).
Transaction Summary of Yarlagadda S Babu
Yarlagadda S Babu Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Yarlagadda S Babu owns 1 companies in total, including BioCryst Pharmaceuticals Inc (BCRX) .
Click here to see the complete history of Yarlagadda S Babu’s form 4 insider trades.
Insider Ownership Summary of Yarlagadda S Babu
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2022-11-14 | VP Drug Discovery |
Yarlagadda S Babu Latest Holdings Summary
Yarlagadda S Babu currently owns a total of 1 stock. Yarlagadda S Babu owns 298,541 shares of BioCryst Pharmaceuticals Inc (BCRX) as of November 14, 2022, with a value of $1 Million.
Latest Holdings of Yarlagadda S Babu
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2022-11-14 | 298,541 | 4.27 | 1,274,770 |
Holding Weightings of Yarlagadda S Babu
Yarlagadda S Babu Form 4 Trading Tracker
According to the SEC Form 4 filings, Yarlagadda S Babu has made a total of 4 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in BioCryst Pharmaceuticals Inc is the sale of 31,515 shares on November 14, 2022, which brought Yarlagadda S Babu around $437,428.
Insider Trading History of Yarlagadda S Babu
- 1
Yarlagadda S Babu Trading Performance
GuruFocus tracks the stock performance after each of Yarlagadda S Babu's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Yarlagadda S Babu is 72.06%. GuruFocus also compares Yarlagadda S Babu's trading performance to market benchmark return within the same time period. The performance of stocks bought by Yarlagadda S Babu within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Yarlagadda S Babu's insider trading performs compared to the benchmark.
Performance of Yarlagadda S Babu
Average Return
151.13%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 85.88 | 72.06 | 190 | 151.13 | 162.55 | 93.97 |
| Relative Return to S&P 500(%) | 83.67 | 64.11 | 195.38 | 136.89 | 139.83 | 85.68 |
Yarlagadda S Babu Ownership Network
Ownership Network List of Yarlagadda S Babu
Ownership Network Relation of Yarlagadda S Babu
Yarlagadda S Babu Owned Company Details
What does BioCryst Pharmaceuticals Inc do?
Who are the key executives at BioCryst Pharmaceuticals Inc?
Yarlagadda S Babu is the VP Drug Discovery of BioCryst Pharmaceuticals Inc. Other key executives at BioCryst Pharmaceuticals Inc include director & CEO Jon P Stonehouse , Vice President and CCO Charles K Gayer , and Exec Director & Finance - PAO Michael L Jones .
BioCryst Pharmaceuticals Inc (BCRX) Insider Trades Summary
Over the past 18 months, Yarlagadda S Babu made 1 insider transaction in BioCryst Pharmaceuticals Inc (BCRX) with a net sale of 31,515. Other recent insider transactions involving BioCryst Pharmaceuticals Inc (BCRX) include a net sale of 411,673 shares made by Jon P Stonehouse , a net sale of 10,125 shares made by Helen M. Thackray , and a net sale of 9,045 shares made by Michael L Jones .
In summary, during the past 3 months, insiders sold 0 shares of BioCryst Pharmaceuticals Inc (BCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 495,199 shares of BioCryst Pharmaceuticals Inc (BCRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 495,199 shares.
BioCryst Pharmaceuticals Inc (BCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioCryst Pharmaceuticals Inc Insider Transactions
Yarlagadda S Babu Mailing Address
Above is the net worth, insider trading, and ownership report for Yarlagadda S Babu. You might contact Yarlagadda S Babu via mailing address: 2190 Parkway Lake Dr, Birmingham Al 35244.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
